Crane Harbor Acquisition Corp. CHAC Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001213900-25-051194
cik 2054174
name CRANE HARBOR ACQUISITION CORP.
sic 6770
countryba US
stprba PA
cityba PHILADELPHIA
zipba 19103
bas1 1845 WALNUT STREET, SUITE 1111
bas2
baph 6468499975
countryma US
stprma PA
cityma PHILADELPHIA
zipma 19103
mas1 1845 WALNUT STREET, SUITE 1111
mas2
countryinc KY
stprinc
ein 000000000
former
changed
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250604
accepted 2025-06-04 16:31:00.0
prevrpt 0
detail 1
instance ea0243656-10q_crane_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001213900-25-051194 20250331 Common Stock Shares Outstanding 7666667.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Founder Shares;
0001213900-25-051194 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 14599.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Common Stock Shares Issued 7666667.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001213900-25-051194 20250331 Common Stock Shares Outstanding 7666667.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B;
0001213900-25-051194 20250331 Common Stock Value USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001213900-25-051194 20250331 Net Income Loss -60434.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-051194 20250331 Preferred Stock Value USD 0 us-gaap/2025
0001213900-25-051194 20241231 Stockholders Equity USD 0 us-gaap/2025
0001213900-25-051194 20241231 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-051194 20241231 Stock Issued During Period Value New Issues 25000.0000 USD 0 us-gaap/2025 Related Party Transaction= Founders Shares; Related Party Transactions By Related Party= Sponsor;
0001213900-25-051194 20250331 Cash 14599.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Net Cash Provided By Used In Financing Activities 42479.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Notes Payable Current 150000.0000 USD 0 us-gaap/2025 Related Party Transactions By Related Party= Related Party;
0001213900-25-051194 20250331 Payments Of Financing Costs 58722.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Prepaid Expenses Applied To Offering Cost 7052.0000 USD 1 0001213900-25-051194
0001213900-25-051194 20241231 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-051194 20250331 Weighted Average Number Of Shares Outstanding Basic 6666667.0000 shares 1 us-gaap/2025 In March 2025, the Company, through a share capitalization, issued the Sponsor an additional 958,334 Class B ordinary shares, as a result of which the Sponsor has purchased and holds an aggregate of 7,666,667 Class B ordinary shares. All share and per share data has been retroactively presented. | Excludes an aggregate of up to 1,000,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full by the underwriters (Note 5).
0001213900-25-051194 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001213900-25-051194 20250331 Common Stock Shares Authorized 50000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B; Includes an aggregate of up to 1,000,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full by the underwriters (Note 5). | In March 2025, the Company, through a share capitalization, issued the Sponsor an additional 958,334 Class B ordinary shares, as a result of which the Sponsor has purchased and holds an aggregate of 7,666,667 Class B ordinary shares.
0001213900-25-051194 20250331 Net Income Loss -60434.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Shares Outstanding 7666667.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001213900-25-051194 20250331 Stockholders Equity 24233.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-051194 20250331 Stock Issued During Period Value New Issues 24233.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-051194 20250331 Assets 290282.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0001213900-25-051194 20250331 General And Administrative Expense 60434.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Liabilities 325716.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Net Cash Provided By Used In Operating Activities -27880.0000 USD 1 us-gaap/2025
0001213900-25-051194 20241231 Stockholders Equity USD 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001213900-25-051194 20250331 Stockholders Equity 767.0000 USD 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001213900-25-051194 20250331 Stockholders Equity -60434.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-051194 20250331 Stock Issued During Period Shares New Issues 7666667.0000 shares 1 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001213900-25-051194 20250331 Stock Issued During Period Value New Issues 767.0000 USD 1 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock; Includes an aggregate of up to 1,000,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full by the underwriters (Note 5). | In March 2025, the Company, through a share capitalization, issued the Sponsor an additional 958,334 Class B ordinary shares, as a result of which the Sponsor has purchased and holds an aggregate of 7,666,667 Class B ordinary shares. All share and per share data has been retroactively presented.
0001213900-25-051194 20250331 Stock Issued During Period Value New Issues USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-051194 20250331 Accrued Liabilities Current And Noncurrent 7930.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025 Class Of Stock= Common Class A;
0001213900-25-051194 20250331 Deferred Offering Costs Included In Accrued Offering Costs 167786.0000 USD 1 0001213900-25-051194
0001213900-25-051194 20250331 Deferred Offerings Costs Paid Through Promissory Note Related Party 38379.0000 USD 1 0001213900-25-051194
0001213900-25-051194 20250331 Earnings Per Share Basic -0.0100 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Earnings Per Share Diluted -0.0100 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Preferred Stock Shares Outstanding shares 0 us-gaap/2025
0001213900-25-051194 20250331 Proceeds From Related Party Debt 101201.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Stock Issued During Period Shares New Issues 958334.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Founder Shares;
0001213900-25-051194 20250331 Stock Issued During Period Shares New Issues 958334.0000 shares 0 us-gaap/2025 Related Party Transaction= Founders Shares; Related Party Transactions By Related Party= Sponsor;
0001213900-25-051194 20250331 Assets Current 18343.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Accrued Offering Costs 167786.0000 USD 0 0001213900-25-051194
0001213900-25-051194 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14599.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Common Stock Shares Issued 7666667.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Founder Shares;
0001213900-25-051194 20250331 Common Stock Value 767.0000 USD 0 us-gaap/2025 Class Of Stock= Common Class B;
0001213900-25-051194 20250331 Deferred Costs 271939.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Liabilities And Stockholders Equity 290282.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-051194 20250331 Prepaid Costs Paid By Sponsor In Exchange 10796.0000 USD 1 0001213900-25-051194
0001213900-25-051194 20241231 Stock Issued During Period Shares New Issues 6708333.0000 shares 0 us-gaap/2025 Equity Components= Founder Shares;
0001213900-25-051194 20250331 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001213900-25-051194 20250331 Common Stock Shares Outstanding shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001213900-25-051194 20250331 Increase Decrease In Accrued Liabilities 7930.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Preferred Stock Shares Issued shares 0 us-gaap/2025
0001213900-25-051194 20250331 Prepaid Expense Current 3744.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Retained Earnings Accumulated Deficit -60434.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Stockholders Equity -35434.0000 USD 0 us-gaap/2025
0001213900-25-051194 20250331 Stock Issued During Period Value New Issues 25000.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Additional Paid In Capital 24233.0000 USD 0 us-gaap/2025
0001213900-25-051194 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents USD 0 us-gaap/2025
0001213900-25-051194 20250331 Common Stock Shares Issued shares 0 us-gaap/2025 Class Of Stock= Common Class A;
0001213900-25-051194 20250331 Costs And Expenses Related Party 10420.0000 USD 1 us-gaap/2025
0001213900-25-051194 20250331 Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares 14204.0000 USD 1 0001213900-25-051194
0001213900-25-051194 20250331 Net Income Loss USD 1 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001213900-25-051194 20250331 Preferred Stock Shares Authorized 5000000.0000 shares 0 us-gaap/2025
0001213900-25-051194 20241231 Shares Outstanding shares 0 us-gaap/2025 Class Of Stock= Common Class B; Equity Components= Common Stock;
0001213900-25-051194 20241231 Stock Issued During Period Shares New Issues 6708333.0000 shares 0 us-gaap/2025 Related Party Transaction= Founders Shares; Related Party Transactions By Related Party= Sponsor;
0001213900-25-051194 20250331 Weighted Average Number Of Diluted Shares Outstanding 6666667.0000 shares 1 us-gaap/2025

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
General And Administrative Expense us-gaap/2025 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Accrued Liabilities Current And Noncurrent us-gaap/2025 0 0 monetary I C Accrued Liabilities Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Proceeds From Related Party Debt us-gaap/2025 0 0 monetary D D Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
Deferred Offerings Costs Paid Through Promissory Note Related Party 0001213900-25-051194 1 0 monetary D D Deferred Offerings Costs Paid Through Promissory Note Related Party Amount of deferred offering costs paid through promissory note - related party.
Prepaid Expenses Applied To Offering Cost 0001213900-25-051194 1 0 monetary D D Prepaid Expenses Applied To Offering Cost Amount of prepaid expenses applied to offering costs.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Additional Paid In Capital us-gaap/2025 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Payments Of Financing Costs us-gaap/2025 0 0 monetary D C Payments of Financing Costs The cash outflow for loan and debt issuance costs.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Accrued Offering Costs 0001213900-25-051194 1 0 monetary I C Accrued Offering Costs Amount of accrued offering costs
Preferred Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Shares Outstanding us-gaap/2025 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Preferred Stock Shares Issued us-gaap/2025 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Stock Issued During Period Shares New Issues us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Notes Payable Current us-gaap/2025 0 0 monetary I C Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
Deferred Costs us-gaap/2025 0 0 monetary I D Deferred Costs, Noncurrent Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Deferred Offering Costs Included In Accrued Offering Costs 0001213900-25-051194 1 0 monetary D D Deferred Offering Costs Included In Accrued Offering Costs Deferred offering costs included in accrued offering costs
Assets Current us-gaap/2025 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Cash us-gaap/2025 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Costs And Expenses Related Party us-gaap/2025 0 0 monetary D D Costs and Expenses, Related Party Costs of sales and operating expenses for the period incurred from transactions with related parties.
Increase Decrease In Accrued Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Preferred Stock Shares Authorized us-gaap/2025 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2025 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Prepaid Expense Current us-gaap/2025 0 0 monetary I D Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Preferred Stock Value us-gaap/2025 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Prepaid Costs Paid By Sponsor In Exchange 0001213900-25-051194 1 0 monetary D D Prepaid Costs Paid By Sponsor In Exchange Amount of prepaid costs paid by the sponsor in exchange for the issuance of Class B ordinary shares.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Stock Issued During Period Value New Issues us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares 0001213900-25-051194 1 0 monetary D D Formation Costs Paid By Sponsor In Exchange For Issuance Of Class BOrdinary Shares Amount of formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001213900-25-051194 4 6 IS 0 H Earnings Per Share Diluted us-gaap/2025 Diluted net loss per Class B ordinary share (in Dollars per share) 0
0001213900-25-051194 5 11 EQ 0 H Stockholders Equity us-gaap/2025 Beginning balance 0
0001213900-25-051194 5 12 EQ 0 H Shares Outstanding us-gaap/2025 Beginning balance (in Shares) 0
0001213900-25-051194 5 13 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2025 Issuance of Class B Ordinary shares to Sponsor 0
0001213900-25-051194 5 14 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2025 Issuance of Class B Ordinary shares to Sponsor (in Shares) 0
0001213900-25-051194 5 15 EQ 0 H Net Income Loss us-gaap/2025 Net loss 0
0001213900-25-051194 5 16 EQ 0 H Stockholders Equity us-gaap/2025 Ending balance 0
0001213900-25-051194 5 17 EQ 0 H Shares Outstanding us-gaap/2025 Ending balance (in Shares) 0
0001213900-25-051194 6 2 CF 0 H Net Income Loss us-gaap/2025 Net loss 0
0001213900-25-051194 6 4 CF 0 H Formation Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares 0001213900-25-051194 Formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares 0
0001213900-25-051194 6 5 CF 0 H Costs And Expenses Related Party us-gaap/2025 Payment of operating expenses through promissory note related party 0
0001213900-25-051194 6 6 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2025 Accrued expenses 0
0001213900-25-051194 6 7 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash used in operating activities 0
0001213900-25-051194 6 9 CF 0 H Proceeds From Related Party Debt us-gaap/2025 Proceeds from promissory note - related party 0
0001213900-25-051194 6 10 CF 0 H Payments Of Financing Costs us-gaap/2025 Payment of deferred offering costs 1
0001213900-25-051194 6 11 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash provided by financing activities 0
0001213900-25-051194 6 12 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2025 Net Change in Cash 0
0001213900-25-051194 6 13 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash Beginning of period 0
0001213900-25-051194 6 14 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash End of period 0
0001213900-25-051194 6 16 CF 0 H Deferred Offering Costs Included In Accrued Offering Costs 0001213900-25-051194 Deferred offering costs included in accrued offering costs 0
0001213900-25-051194 6 17 CF 0 H Deferred Offerings Costs Paid Through Promissory Note Related Party 0001213900-25-051194 Deferred offering costs paid through promissory note - related party 0
0001213900-25-051194 6 18 CF 0 H Prepaid Costs Paid By Sponsor In Exchange 0001213900-25-051194 Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares 0
0001213900-25-051194 6 19 CF 0 H Prepaid Expenses Applied To Offering Cost 0001213900-25-051194 Prepaid expenses applied to deferred offering costs 0
0001213900-25-051194 2 11 BS 0 H Cash us-gaap/2025 Cash 0
0001213900-25-051194 2 12 BS 0 H Prepaid Expense Current us-gaap/2025 Prepaid expenses 0
0001213900-25-051194 2 13 BS 0 H Assets Current us-gaap/2025 Total Current Assets 0
0001213900-25-051194 2 14 BS 0 H Deferred Costs us-gaap/2025 Deferred offering costs 0
0001213900-25-051194 2 15 BS 0 H Assets us-gaap/2025 Total Assets 0
0001213900-25-051194 2 17 BS 0 H Accrued Liabilities Current And Noncurrent us-gaap/2025 Accrued expenses 0
0001213900-25-051194 2 18 BS 0 H Accrued Offering Costs 0001213900-25-051194 Accrued offering costs 0
0001213900-25-051194 2 19 BS 0 H Notes Payable Current us-gaap/2025 Promissory note - related party 0
0001213900-25-051194 2 20 BS 0 H Liabilities us-gaap/2025 Total Liabilities 0
0001213900-25-051194 2 21 BS 0 H Commitments And Contingencies us-gaap/2025 Commitments and Contingencies 0
0001213900-25-051194 2 23 BS 0 H Preferred Stock Value us-gaap/2025 Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued or outstanding 0
0001213900-25-051194 2 24 BS 0 H Common Stock Value us-gaap/2025 Common stock value 0
0001213900-25-051194 2 25 BS 0 H Additional Paid In Capital us-gaap/2025 Additional paid-in capital 0
0001213900-25-051194 2 26 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Accumulated deficit 0
0001213900-25-051194 2 27 BS 0 H Stockholders Equity us-gaap/2025 Total Shareholders Deficit 0
0001213900-25-051194 2 28 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total Liabilities and Shareholders Deficit 0
0001213900-25-051194 3 7 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2025 Preferred stock, par value (in Dollars per share) 0
0001213900-25-051194 3 8 BS 1 H Preferred Stock Shares Authorized us-gaap/2025 Preferred stock, shares authorized 0
0001213900-25-051194 3 9 BS 1 H Preferred Stock Shares Issued us-gaap/2025 Preferred stock, shares issued 0
0001213900-25-051194 3 10 BS 1 H Preferred Stock Shares Outstanding us-gaap/2025 Preferred stock, shares outstanding 0
0001213900-25-051194 3 11 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in Dollars per share) 0
0001213900-25-051194 3 12 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares authorized 0
0001213900-25-051194 3 13 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued 0
0001213900-25-051194 3 14 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares outstanding 0
0001213900-25-051194 4 1 IS 0 H General And Administrative Expense us-gaap/2025 Formation and general and administrative costs 0
0001213900-25-051194 4 2 IS 0 H Net Income Loss us-gaap/2025 Net loss 0
0001213900-25-051194 4 3 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 Weighted average Class B shares outstanding, basic (in Shares) 0
0001213900-25-051194 4 4 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 Weighted average Class B ordinary shares outstanding, diluted (in Shares) 0
0001213900-25-051194 4 5 IS 0 H Earnings Per Share Basic us-gaap/2025 Basic net loss per share, Class B ordinary shares (in Dollars per share) 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.